4 results
Approved WMOCompleted
To determine the safety and efficacy of coversin in the treatment of patients with PNH resistant to eculizumab.
Approved WMOCompleted
* The purpose of this study is to to determine the safety profile of long-termCoversin treatment.* To observe the long term safety and efficacy of Coversin over periods in excess of 6 months* To assess the long term patient acceptability of Coversin…
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMOPending
The purpose of this study is to compare event-free survival (EFS) in participants with Bacillus Calmette-Guerin (BCG)-naive high-risk non-muscle invasive bladder cancer (HR-NMIBC), including high-grade papillary Ta, any T1, or carcinoma in situ (CIS…